1. Home
  2. PTCT vs CWEN Comparison

PTCT vs CWEN Comparison

Compare PTCT & CWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • CWEN
  • Stock Information
  • Founded
  • PTCT 1998
  • CWEN 2012
  • Country
  • PTCT United States
  • CWEN United States
  • Employees
  • PTCT N/A
  • CWEN N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • CWEN Electric Utilities: Central
  • Sector
  • PTCT Health Care
  • CWEN Utilities
  • Exchange
  • PTCT Nasdaq
  • CWEN Nasdaq
  • Market Cap
  • PTCT 5.3B
  • CWEN 3.8B
  • IPO Year
  • PTCT 2013
  • CWEN 2013
  • Fundamental
  • Price
  • PTCT $75.70
  • CWEN $36.03
  • Analyst Decision
  • PTCT Buy
  • CWEN Buy
  • Analyst Count
  • PTCT 17
  • CWEN 6
  • Target Price
  • PTCT $73.24
  • CWEN $37.17
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • CWEN 1.2M
  • Earning Date
  • PTCT 11-04-2025
  • CWEN 11-04-2025
  • Dividend Yield
  • PTCT N/A
  • CWEN 4.91%
  • EPS Growth
  • PTCT N/A
  • CWEN 125.75
  • EPS
  • PTCT 8.94
  • CWEN 2.34
  • Revenue
  • PTCT $1,779,150,000.00
  • CWEN $1,375,000,000.00
  • Revenue This Year
  • PTCT $119.02
  • CWEN $5.03
  • Revenue Next Year
  • PTCT N/A
  • CWEN $13.19
  • P/E Ratio
  • PTCT $8.42
  • CWEN $15.31
  • Revenue Growth
  • PTCT 97.54
  • CWEN 0.81
  • 52 Week Low
  • PTCT $35.95
  • CWEN $24.40
  • 52 Week High
  • PTCT $76.80
  • CWEN $36.06
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 79.67
  • CWEN 78.04
  • Support Level
  • PTCT $69.23
  • CWEN $34.88
  • Resistance Level
  • PTCT $73.98
  • CWEN $35.95
  • Average True Range (ATR)
  • PTCT 2.67
  • CWEN 0.93
  • MACD
  • PTCT 0.40
  • CWEN 0.26
  • Stochastic Oscillator
  • PTCT 89.08
  • CWEN 99.79

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About CWEN Clearway Energy Inc. Class C

Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and owner of modern, sustainable and long-term contracted assets across North America. The company segments its operations into Flexible Generation, renewables and Corporate divisions.

Share on Social Networks: